Pressrelease – Lund, June 29th, 2026 – Hamlet BioPharma Receives European Regulatory Approval for Phase III Study of Alpha1H in Bladder Cancer June 29, 2026
Pressrelease – Lund, 29 Juni, 2026 – Briefglance uppmärksammar Hamlet BioPharmas samarbete med Universitetet i Iowa och potentialen för behandling av svår blåscancer June 29, 2026
Pressrelease – Lund, June 25th, 2026 – Hamlet BioPharma secures drug manufacturing at Phase III quality and release of Alpha1H for distribution to clinical trial sites June 25, 2026
Pressrelease – Lund, June 23rd, 2026 – Hamlet BioPharma’s monthly digital investors’ meeting on June 30th June 23, 2026
